Telmisartan amlodipine combination
Showing 1 - 25 of >10,000
Essential Hypertension Trial in Korea, Republic of (Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg,
Not yet recruiting
- Essential Hypertension
- Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg
- Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mg
-
Seoul, Gyeonggi-do, Korea, Republic of
- +11 more
Sep 11, 2023
Patients Treated With Telmisartan/Hydrochlorothiazide or
Withdrawn
- Hypertension
- subjects treated with telmisartan/hydrochlorothiazide
- +3 more
-
Tokyo, JapanNippon Boehringer Ingelheim Co., Ltd.
Jun 23, 2022
Hypertension, Potassium Imbalance Trial in Dhaka (Fixed Dose Combination pill of Telmisartan 40mg and Amlodipine 5 mg)
Recruiting
- Hypertension
- Potassium Imbalance
- Fixed Dose Combination pill of Telmisartan 40mg and Amlodipine 5 mg
-
Dhaka, BangladeshNational Heart Foundation of Bangladesh
Jan 21, 2022
Hypertension Trial in Australia, United States (Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg, Telmisartan 20
Recruiting
- Hypertension
- Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg
- +2 more
-
Tampa, FloridaPrecision Research Center
Dec 13, 2021
Hypertension Trial in Worldwide (Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg, telmisartan 40 mg/amlodipine 5
Recruiting
- Hypertension
- Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg
- +7 more
-
Phoenix, Arizona
- +84 more
Aug 19, 2022
Hypercholesterolemia, Hypertension Trial in Seoul (Ezetimibe/Rosuvastatin, Telmisartan, Telmisartan/Amlodipine 80 Mg-5 Mg ORAL
Completed
- Hypercholesterolemia
- Hypertension
- Ezetimibe/Rosuvastatin
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
May 10, 2021
Dyslipidemias, Hypertension Trial in Daegu (Rosuampin 10/5mg, Rosuampin 20/5mg, Amlodipine/Atorvastatin 5/20mg)
Completed
- Dyslipidemias
- Hypertension
- Rosuampin 10/5mg
- +2 more
-
Daegu, Korea, Republic ofDaegu Catholic Univ. Medical Center
Oct 10, 2022
Healthy Volunteers Trial in Seoul (Irbesartan High/Amlodipine FDC, Irbesartan High, Amlodipine)
Active, not recruiting
- Healthy Volunteers
- Irbesartan High/Amlodipine FDC
- +2 more
-
Seoul, Korea, Republic ofH Plus Yangji Hospital
Jan 26, 2023
Healthy Volunteers Trial in Seoul (Irbesartan/Amlodipine FDC, Irbesartan, Amlodipine)
Active, not recruiting
- Healthy Volunteers
- Irbesartan/Amlodipine FDC
- +2 more
-
Seoul, Korea, Republic ofH Plus Yangji Hospital
Jan 8, 2023
Healthy Volunteers Trial in Seoul (Irbesartan/Amlodipine High FDC, Irbesartan, Amlodipine High)
Active, not recruiting
- Healthy Volunteers
- Irbesartan/Amlodipine High FDC
- +2 more
-
Seoul, Korea, Republic ofH Plus Yangji Hospital
Jan 8, 2023
Amlodipine/Atorvastatin/Perindopril Single Pill Combination
Not yet recruiting
- Arterial Hypertension
- HTN
- Amlodipine 5 mg + atorvastatin 10 mg + perindopril arginine 5 mg
- +2 more
- (no location specified)
Mar 1, 2023
Hypertension, Hyperlipidemias Trial in Seoul (Amlodipine/Olmesartan 10/40mg (Combination drug), Rosuvastatin 20mg, Olmesartan 40
Completed
- Hypertension
- Hyperlipidemias
- Amlodipine/Olmesartan 10/40mg (Combination drug), Rosuvastatin 20mg
- +2 more
-
Seoul, Korea, Republic ofSeoul national university bundang hospital
Dec 20, 2021
Hypertension Trial (Losartan (+) amlodipine, Placebo to match losartan/amlodipine tablets, Amlodipine camsylate)
Completed
- Hypertension
- Losartan (+) amlodipine
- +3 more
- (no location specified)
Feb 7, 2022
ASCVD, Impaired Fasting Glucose, Hypertension Trial in Seongnam-si, Cheonan, Seoul (Duowell®, Monorova® + Amlopin®)
Completed
- ASCVD
- +2 more
- Duowell®
- Monorova® + Amlopin®
-
Seongnam-si, Gyeonggi-do, Korea, Republic of
- +3 more
May 31, 2021
Hypertension Trial in Korea, Republic of (Telminuvo®Tab. 40/2.5mg, Telmitrend®Tab. 80mg)
Completed
- Hypertension
- Telminuvo®Tab. 40/2.5mg
- Telmitrend®Tab. 80mg
-
Gyeonggi-do, Ansan-si, Korea, Republic of
- +10 more
Jan 29, 2020
Hypertension Trial in China (Fixed [Per/Ind/Aml], Free [Per/Ind + Aml])
Completed
- Hypertension
- Fixed [Per/Ind/Aml]
- Free [Per/Ind + Aml]
-
Beijing, Beijing, China
- +41 more
Apr 18, 2023
Micatrio® Combination Tablets Treatment in Hypertension
Completed
- Hypertension
- T80/A5/H12.5 FDC
-
Tokyo, JapanNippon Boehringer Ingelheim Co., Ltd
May 7, 2020
Hypertension,Essential Trial in Seoul (AD209, Amlodipine low, Amlodipine high)
Completed
- Hypertension,Essential
- AD209
- +3 more
-
Seoul, Korea, Republic ofKorea University Guro Hospital
Jul 20, 2021
Essential Hypertension Trial in Seoul (Fimasartan/Amlodipine)
Completed
- Essential Hypertension
-
Seoul, Korea, Republic ofBoryung Pharmaceutical Co., Ltd
Jul 28, 2021
Essential Hypertension Trial in Russian Federation (Amlodipine 5mg + bisoprolol fumarate 5mg + perindopril arginine 5mg, Norvasc
Completed
- Essential Hypertension
- Amlodipine 5mg + bisoprolol fumarate 5mg + perindopril arginine 5mg
- +3 more
-
Barnaul, Altai Region, Russian Federation
- +14 more
Aug 3, 2022
Angiotensin/Renin/Aldosterone Hypertension, Hypertension, Diabetes, Type 2 Trial in Seongnam (Olmesartan)
Recruiting
- Angiotensin/Renin/Aldosterone Hypertension
- +2 more
-
Seongnam, Gyeonggi, Korea, Republic ofSeoul National University Bundang Hospital
Aug 16, 2022
Stroke, Cerebral Small Vessel Diseases, Intracerebral Hemorrhage Trial in Liverpool, Birtinya, Melbourne (telmisartan 20 mg +
Terminated
- Stroke
- +4 more
- telmisartan 20 mg + amlodipine 2.5mg + indapamide 1.25mg
- Placebo oral capsule
-
Liverpool, New South Wales, Australia
- +2 more
May 24, 2021